Retinal thickness as a potential biomarker in patients with amyloid‐proven early‐ and late‐onset Alzheimer's disease

Retinal thickness as a potential biomarker in patients with amyloid‐proven early‐ and late‐onset Alzheimer's disease

Abstract Introduction Retinal thickness measured with optical coherence tomography has been proposed as a noninvasive biomarker for Alzheimer's disease (AD). We therefore measured retinal thickness in well‐characterized AD and control participants, considering ophthalmological confounders. Meth...

Full description

Bibliographic Details
Main Authors: Jurre denHaan, Jacoba A. van deKreeke, Elles Konijnenberg, Mara tenKate, Anouk denBraber, Frederik Barkhof, Bart N. vanBerckel, Charlotte E. Teunissen, Philip Scheltens, Pieter Jelle Visser, Frank D. Verbraak, Femke H. Bouwman
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Retinal thickness
Cortical atrophy
Alzheimer's disease
Neurodegeneration
Biomarker
Online Access:https://doi.org/10.1016/j.dadm.2019.05.002

Internet

https://doi.org/10.1016/j.dadm.2019.05.002

Similar Items